report-image

Genomics Market Size And Forecast (2020 - 2035), Global And Regional Growth, Trend, Share And Industry Analysis Report Coverage: By Type (Products, Services), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Others), By Application (Drug Discovery And Development, Diagnostics, Precision Medicine, Agriculture And Animal Research, Other Applications), By End-User (Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROS)) And Geography.

  • PUBLISHED ON
  • 2025-03-25
  • NO OF PAGES
  • 269
  • CATEGORY
  • Healthcare & Life Sciences

Genomics Market Overview

The global genomics market is witnessing significant expansion, driven by rapid technological advancements, increasing research initiatives, and growing applications in personalized medicine, drug discovery, and disease diagnostics. By 2025, the market is projected to reach a value of around USD 34.2 Billion. Looking ahead to 2035, it is expected to expand further to about USD 66.4 Billion. This represents an annual growth rate of 14.6% over the ten-year period.

Genomics, or gene structure and function study, has revolutionized healthcare by enabling early detection of diseases, targeted therapies, and precision medicine. The convergence of artificial intelligence (AI), big data analytics, and next-generation sequencing (NGS) technology is making genomics market size grow at a high rate. According to genomics market analysis, increasing adoption of genome sequencing, gene editing technology like CRISPR, and bioinformatics solutions is also propelling market growth. The increase in incidence of genetic disorders, cancer, and rare diseases is driving demand for genomics-based therapeutics and diagnostics, making industry growth more substantial.

Further, advances in NGS technology, whole genome sequencing, and microarray technology have led to a steep decline in sequencing prices, making it more affordable to conduct genomic testing. Government initiatives, research grant programs, and pharmaceutical company and research institute collaborations are also fueling genomics-driven drug development and biomarker studies. The demand for precision oncology and personalized medicine is also fueling genomics solution adoption in clinics. The growing focus on gene therapy, synthetic biology, and integration of genetic information is also widening genomics application areas in biotechnology, agriculture, and forensics. Therefore, as genomics continues to revolutionize healthcare, prevention of diseases, and personalized therapies, the industry will continue to grow with market trends indicating ongoing innovations and widening adoption globally.

 

Genomics Market Drivers and Opportunities

Next-generation sequencing (NGS) and genome editing technologies advancements will drive the genomics market to grow over the forecast period

Amongst some of the primary drivers of the worldwide genomics market growth is the rapid pace of advancement in next-generation sequencing (NGS) and genome editing technology. The evolution of NGS has revolutionized genetic research through enhanced speed, accuracy, and reduced cost of sequencing entire genomes. The cost reduction of genome sequencing through advances in high-throughput sequencing platforms and informatics software has allowed genomic research to become more accessible to healthcare centers, pharmaceutical companies, and academic scientists.

Genome editing technologies like CRISPR-Cas9 have also driven genomics market growth with efficient and accurate gene modification capabilities. The advancements have enabled scientists to correct genetic mutations, design targeted gene therapies, and propel synthetic biology applications. Genomics market studies indicate that continued investment in gene-editing technologies, automation, and artificial intelligence-based genome sequencing platforms is transforming the landscape of genomic medicine. As demand for gene-based therapies, customized medicines, and rare disease diagnosis continues to rise, NGS and genome editing will remain at the forefront of the anticipated genomics market expansion. The adoption of cloud computing, big data analytics, and artificial intelligence (AI) in genomics research is also on the rise and simplifying data interpretation and accelerating discoveries. The collaboration between biotechnology companies, research institutes, and healthcare providers is also driving advancements in whole-genome sequencing, transcriptomics, and epigenomics and propelling genomics-based healthcare solutions adoption.

Rising incidence of genetic disorders and cancer is a significant driver in influencing the growth of the global genomics market

The increase in genetic disorders, orphan diseases, and cancer is another primary driver of the genomics market. Genetic mutations lead to a wide range of hereditary disorders such as cystic fibrosis, sickle cell anemia, muscular dystrophy, and Huntington’s disease, driving demand for advanced genomic testing and early diagnosis. As genetic disorders have a high hereditary component, predictive genetic testing, carrier testing, and prenatal testing have gained popularity, propelling the genomics market size.

Cancer, a leading cause of death globally, has also become a primary target of genomic research and precision oncology. The ability to sequence tumors and identify genetic mutations allows oncologists to design personalized treatment regimens, targeted therapies, and immunotherapies based on a patient's genetic profile. Genomic profiling has unveiled possibilities for liquid biopsy technologies that make use of circulating tumor DNA (ctDNA) to detect cancer at an early stage and monitor the evolution of disease non-invasively. Genomics market research suggests that continuous advancements in cancer genomics, pharmacogenomics, and biomarker discovery fuel research into new therapies and improve patient survival rates.

Government agencies and research institutes worldwide are investing significantly in genomics medicine and precision healthcare, hence driving market growth. For instance, in January 2023, SOPHiA GENETIC collaborated with Memorial Sloan Kettering Cancer Center (MSK), a U.S. Cancer Center, to offer scientists and clinicians solutions to enhance analytical and testing capacity. As more individuals become knowledgeable about genomics applications in preventing illness, early detection, and precision medicine, healthcare is witnessing a rapid adoption of genomics technology, driving forecasted expansion trends in the genomics market.

Integrating AI and Big Data in Genomic Research

The intersection of artificial intelligence (AI) and big data analytics is enabling new frontiers in genomics research, pharmaceutical discovery, and medical diagnosis. Artificial intelligence-powered algorithms can analyze vast amounts of genomic data to recognize patterns of illness and predict treatment outcomes with precision. Bioinformatics software, machine learning algorithms, and deep-learning platforms are facilitating genomic sequencing, gene-expression studies, and biomarker discovery. Based on genomics market forecast trends, applications of predictive genomics through artificial intelligence, cloud-based platforms of bioinformatics, and automated genome interpretation are transforming healthcare and biotechnology industries. Future development of genomics AI platforms will enhance research capabilities immensely, accelerate innovations, and create new opportunities in prevention of diseases, regenerative medicine, and uses of synthetic biology

Genomics Market Scope

Report Attributes

Description

Market Size in 2025

USD 34.2 Billion

Market Forecast in 2035

USD 66.4 Billion

CAGR % 2025-2035

14.6%

Base Year

2024

Historic Data

2020-2024

Forecast Period

2025-2035

Report USP

 

Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

  • By Type
  • By Technology
  • By Application
  • By End-user

Regional Scope

  • North America,
  • Europe,
  • APAC,
  • Latin America
  • Middle East and Africa

Country Scope

  1. U.S.
  2. Canada
  3. U.K.
  4. Germany
  5. France
  6. Italy
  7. Spain
  8. Benelux
  9. Nordic Countries
  10. Russia
  11. China
  12. India
  13. Japan
  14. South Korea
  15. Australia
  16. Indonesia
  17. Thailand
  18. Mexico
  19. Brazil
  20. Argentina
  21. Saudi Arabia
  22. UAE
  23. Egypt
  24. South Africa
  25. Nigeria

Genomics Market Report Segmentation Analysis

The global genomics market industry analysis is segmented into by Type, by Technology, by Application, by End-user and by Region.

The Type segment will have the highest market share in the global genomics market during the forecast period.

By Type, market is segmented into products and services, with products being the dominant segment with 52.0% market share. Products segment includes instruments & software and consumables, both of which have a key function in genomic research, clinical diagnostics, and drug discovery. Demand for next-generation sequencing (NGS) platforms, PCR systems, microarrays, and bioinformatics software is driving high growth in this segment. Adoption of genomics-based healthcare solutions, precision medicine, and genomic data analysis through artificial intelligence is also driving market expansion. Genomics market analysis states that products have the largest market share due to continuous advances in sequencing technology, automation, and data analytics software that is making genomic studies more efficient and precise.


The Polymerase Chain Reaction (PCR) dominated the market in 2024 and is projected to grow at the highest CAGR over the forecast period.

Based on technology type, genomics market is segmented into Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, and Others. In 2025, Polymerase Chain Reaction (PCR) will dominate the market. PCR is a prevalent technology applied in genomic research, clinical diagnosis, forensic uses, and infectious diseases testing that accounts for its significant market share in genomics market size. The demand for PCR-based gene testing, molecular testing, and targeted gene amplification techniques is a key adoption driver. Genomics market study suggests that low cost, high accuracy, and rapid processing of PCR have been driving factors to make it a market leader.

The diagnostics segment is predicted to grow at the highest CAGR over the forecast period.

Application market is divided into Drug Discovery and Development, Diagnostics, Precision Medicine, Agriculture and Animal Research, and Other Applications. In 2025, Diagnostics being the largest application segment market. The increasing demand for genomics-based diagnostic products to diagnose diseases, genetic conditions, and early-stage cancers has been driving this application market in genomics market size. With the growing prevalence of genetic disorders, rare diseases, and infectious diseases, genomics-driven diagnostics have become essential for early disease detection, risk assessment, and personalized treatment planning.

The Pharmaceutical & Biotechnological Companies segment is expected to dominate the market during the forecast period.

End user genomics market is segmented into Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, and Contract Research Organizations (CROs), with Pharmaceutical & Biotechnological Companies accounting for the largest share. Pharmaceutical & Biotechnological Companies drive genomics-based drug development, precision medicine, gene therapy research, and biomarker studies that drive genomics market size growth.

The following segments are part of an in-depth analysis of the global genomics market:

Market Segments

By Type

  • Products
  • Instruments & Software
  • Consumables
  • Services

By Technology

  • Polymerase Chain Reaction (PCR)
  • Next-generation Sequencing (NGS)
  • Microarray
  • Sanger Sequencing
  • Others

By Application

  • Drug Discovery and Development
  • Diagnostics
  • Precision Medicine
  • Agriculture and Animal Research
  • Other Applications

By End-user

  • Research Institutes
  • Healthcare Facilities & Diagnostic Centers
  • Pharmaceutical & Biotechnological Companies
  • Contract Research Organization (CROs)

Genomics Market Share Analysis by Region

North America is projected to hold the largest share of the global genomics market over the forecast period.

By 2025, North America has the largest market share of 44.1% in genomics market size with top biotechnology and pharmaceutical players present in the region, well-developed healthcare infrastructure, and high government expenditure in genomic research. The demand for next-generation sequencing (NGS), polymerase chain reaction (PCR), and genome editing technologies is driving genomics market growth in North America. The rising adoption of precision medicine, targeted therapies, and genomics-based tests is also supporting the region's market supremacy. According to genomics market studies, rising cases of cancer, genetic disorders, and orphan diseases have led to more genomic testing, biomarker discovery, and applications of pharmacogenomics in the region. Government initiatives such as the All of Us Research Program and 100,000 Genomes Project are supporting advancements in genomic medicine, AI-based genetic analytics, and cloud-based genomic information storage solutions. In addition, leading research institutions and biopharmaceutical companies investing in gene therapy, synthetic biology, and CRISPR gene-editing technology in North America propel the forecasted growth of the genomics market. The adoption of automation, bioinformatics software, and AI-based genomic platforms will continue to drive innovations to help North America remain at the forefront of global genomics market trends.

However, Asia-Pacific (APAC) is poised to have the highest CAGR in genomics market forecast trends. The region is experiencing accelerated development with more biotechnology research, government investment in genomic medicine, and healthcare infrastructure improvements. The demand for genomic sequencing, precision diagnosis, and artificial intelligence-based bioinformatics solutions is rising in countries like China, India, and Japan. As more focus is being placed on genetic research, disease prevention, and genome-based pharmaceutical development, APAC is poised to be a driving factor in shaping the genomics market of tomorrow.

Genomics Market Competition Landscape Analysis

the global genomics market is poised for significant growth, with key players investing heavily in technology and infrastructure. These companies are actively engaged in research and development, strategic partnerships, and large-scale project implementations to enhance their market positions. ​

Global Genomics Market Recent Developments News:

In May 2024, Sophia Genetics announced that it will be collaborating with Microsoft and NVIDIA to harness their technology and genomics capabilities to offer a streamlined and scalable solution to healthcare institutions to perform whole genome sequencing (WGS) analyses with a vision to make it accessible to customers within a year.

In May 2024, Bruker Corporation announced that it had finalized its acquisition of NanoString Technologies, Inc.'s business. The acquisition strengthened its portfolio as the company has now finalized acquiring substantially all of the assets and rights to NanoString's business, including nCounter, GeoMx, CosMx and AtoMx product offerings, at approximately USD 392.6 million in cash and with the assumption of some liabilities. 

The global genomics market is dominated by a few large companies, such as

·         Abbott

·         Agilent Technologies, Inc.

·         BD

·         BGI Group

·         Bio-Rad Laboratories, Inc.

·         Charles River Laboratories

·         Danaher Corporation

·         Eppendorf SE

·         Eurofins Scientific

·         F. Hoffmann-La Roche Ltd.

·         Illumina, Inc.

·         IQVIA Inc.

·         Merck KGaA

·         Oxford Nanopore Technologies plc.

·         Thermo Fisher Scientific Inc.

·         Others                                                                                       


1.      Global Genomics Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Genomics Market Scope and Market Estimation

1.2.1. Global Genomics Overall Market Size (US$ Bn), Market CAGR (%), Market forecast (2025 - 2035)

1.2.2. Global Genomics Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2021 - 2035

1.3.    Market Segmentation

1.3.1. Type of Global Genomics Market

1.3.2. Technology of Global Genomics Market

1.3.3. Application of Global Genomics Market

1.3.4. End User of Global Genomics Market

1.3.5. Region of Global Genomics Market

2.      Executive Summary

2.1.    Demand Side Trends

2.2.    Key Market Trends

2.3.    Market Demand (US$ Bn) Analysis 2021 – 2024 and Forecast, 2025 – 2035

2.4.    Demand and Opportunity Assessment

2.5.    Demand Supply Scenario

2.6.    Market Dynamics

2.6.1. Drivers

2.6.2. Limitations

2.6.3. Opportunities

2.6.4. Impact Analysis of Drivers and Restraints

2.7.    Pricing Trends Analysis

2.8.    Overview of Technology Developments

2.9.    Porter’s Five Forces Analysis

2.9.1. Bargaining Power of Suppliers

2.9.2. Bargaining Power of Buyers

2.9.3. Threat of Substitutes

2.9.4. Threat of New Entrants

2.9.5. Competitive Rivalry

2.10.  PEST Analysis

2.10.1.   Political Factors

2.10.2.   Economic Factors

2.10.3.   Social Factors

2.10.4.   Technology Factors

2.11.  Value Chain / Ecosystem Analysis

2.12.  Key Regulation

3.      Global Genomics Market Estimates & Historical Trend Analysis (2021 - 2024)

4.      Global Genomics Market Estimates & Forecast Trend Analysis, by Type

4.1.    Global Genomics Market Revenue (US$ Bn) Estimates and Forecasts, by Type, 2021 - 2035

4.1.1. Products

4.1.1.1.              Instruments & Software

4.1.1.2.              Consumables

4.1.2. Services

5.      Global Genomics Market Estimates & Forecast Trend Analysis, by Technology

5.1.    Global Genomics Market Revenue (US$ Bn) Estimates and Forecasts, by Technology, 2021 - 2035

5.1.1. Polymerase Chain Reaction (PCR)

5.1.2. Next-generation Sequencing (NGS)

5.1.3. Microarray

5.1.4. Sanger Sequencing

5.1.5. Others

6.      Global Genomics Market Estimates & Forecast Trend Analysis, by Application

6.1.    Global Genomics Market Revenue (US$ Bn) Estimates and Forecasts, by Application, 2021 - 2035

6.1.1. Drug Discovery and Development

6.1.2. Diagnostics

6.1.3. Precision Medicine

6.1.4. Agriculture and Animal Research

6.1.5. Other Applications

7.      Global Genomics Market Estimates & Forecast Trend Analysis, by End User

7.1.    Global Genomics Market Revenue (US$ Bn) Estimates and Forecasts, by End User, 2021 - 2035

7.1.1.Research Institutes

7.1.2.Healthcare Facilities & Diagnostic Centers

7.1.3.Pharmaceutical & Biotechnological Companies

7.1.4.Contract Research Organization (CROs)

8.      Global Genomics Market Estimates & Forecast Trend Analysis, by Region

8.1.    Global Genomics Market Revenue (US$ Bn) Estimates and Forecasts, by Region, 2021 - 2035

8.1.1. North America

8.1.2. Eastern Europe

8.1.3. Western Europe

8.1.4. Asia Pacific

8.1.5. Middle East & Africa

8.1.6. Latin America

9.      North America Genomics Market: Estimates & Forecast Trend Analysis

9.1.    North America Genomics Market Assessments & Key Findings

9.1.1. North America Genomics Market Introduction

9.1.2. North America Genomics Market Size Estimates and Forecast (US$ Billion) (2021 - 2035)

9.1.2.1.   By Type

9.1.2.2.   By Technology

9.1.2.3.   By Application

9.1.2.4.   By End User

9.1.2.5.   By Country

9.1.2.5.1.     The U.S.

9.1.2.5.2.     Canada

9.1.2.5.3.     Mexico

10.  Western Europe Genomics Market: Estimates & Forecast Trend Analysis

10.1.  Western Europe Genomics Market Assessments & Key Findings

10.1.1.   Western Europe Genomics Market Introduction

10.1.2.   Western Europe Genomics Market Size Estimates and Forecast (US$ Billion) (2021 - 2035)

10.1.2.1.    By Type

10.1.2.2.    By Technology

10.1.2.3.    By Application

10.1.2.4.    By End User

10.1.2.5.    By Country

10.1.2.5.1.  Germany

10.1.2.5.2.  Italy

10.1.2.5.3.  U.K.

10.1.2.5.4.  France

10.1.2.5.5.  Spain

10.1.2.5.6.  Benelux

10.1.2.5.7.  Nordics

10.1.2.5.8. Rest of W. Europe

11.  Eastern Europe Genomics Market: Estimates & Forecast Trend Analysis

11.1.  Eastern Europe Genomics Market Assessments & Key Findings

11.1.1.   Eastern Europe Genomics Market Introduction

11.1.2.   Eastern Europe Genomics Market Size Estimates and Forecast (US$ Billion) (2021 - 2035)

11.1.2.1.    By Type

11.1.2.2.    By Technology

11.1.2.3.    By Application

11.1.2.4.    By End User

11.1.2.5.    By Country

11.1.2.5.1.  Russia

11.1.2.5.2.  Hungary

11.1.2.5.3.  Poland

11.1.2.5.4.  Balkan & Baltics

11.1.2.5.5. Rest of E. Europe

12.  Asia Pacific Genomics Market: Estimates & Forecast Trend Analysis

12.1.  Asia Pacific Market Assessments & Key Findings

12.1.1.   Asia Pacific Genomics Market Introduction

12.1.2.   Asia Pacific Genomics Market Size Estimates and Forecast (US$ Billion) (2021 - 2035)

12.1.2.1.    By Type

12.1.2.2.    By Technology

12.1.2.3.    By Application

12.1.2.4.    By End User

12.1.2.5.    By Country

12.1.2.5.1. China

12.1.2.5.2. Japan

12.1.2.5.3. India

12.1.2.5.4. Australia & New Zealand

12.1.2.5.5. South Korea

12.1.2.5.6. ASEAN

12.1.2.5.7. Rest of Asia Pacific

13.  Middle East & Africa Genomics Market: Estimates & Forecast Trend Analysis

13.1.  Middle East & Africa Market Assessments & Key Findings

13.1.1.   Middle East & Africa Genomics Market Introduction

13.1.2.   Middle East & Africa Genomics Market Size Estimates and Forecast (US$ Billion) (2021 - 2035)

13.1.2.1.    By Type

13.1.2.2.    By Technology

13.1.2.3.    By Application

13.1.2.4.    By End User

13.1.2.5.    By Country

13.1.2.5.1. UAE

13.1.2.5.2. Saudi Arabia

13.1.2.5.3. Turkey

13.1.2.5.4. South Africa

13.1.2.5.5. Rest of MEA

14.  Latin America Genomics Market: Estimates & Forecast Trend Analysis

14.1.  Latin America Market Assessments & Key Findings

14.1.1.   Latin America Genomics Market Introduction

14.1.2.   Latin America Genomics Market Size Estimates and Forecast (US$ Billion) (2021 - 2035)

14.1.2.1.    By Type

14.1.2.2.    By Technology

14.1.2.3.    By Application

14.1.2.4.    By End User

14.1.2.5.    By Country

14.1.2.5.1. Brazil

14.1.2.5.2. Argentina

14.1.2.5.3. Colombia

14.1.2.5.4. Rest of LATAM

15.  Country Wise Market: Introduction

16.  Competition Landscape

16.1.  Global Genomics Market Product Mapping

16.2.  Global Genomics Market Concentration Analysis, by Leading Players / Innovators / Emerging Players / New Entrants

16.3.  Global Genomics Market Tier Structure Analysis

16.4.  Global Genomics Market Concentration & Company Market Shares (%) Analysis, 2023

17.  Company Profiles

17.1.      Abbott

17.1.1.   Company Overview & Key Stats

17.1.2.   Financial Performance & KPIs

17.1.3.   Product Portfolio

17.1.4.   SWOT Analysis

17.1.5.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

17.2.      Abbott

17.3.      Agilent Technologies, Inc.

17.4.      BD

17.5.      BGI Group

17.6.      Bio-Rad Laboratories, Inc.

17.7.      Charles River Laboratories

17.8.      Danaher Corporation

17.9.      Eppendorf SE

17.10.  Eurofins Scientific

17.11.  F. Hoffmann-La Roche Ltd.

17.12.  Illumina, Inc.

17.13.  IQVIA Inc.

17.14.  Merck KGaA

17.15.  Oxford Nanopore Technologies plc.

17.16.  Thermo Fisher Scientific Inc.

17.17.  Others     

18.  Research Methodology

18.1.  External Transportations / Databases

18.2.  Internal Proprietary Database

18.3.  Primary Research

18.4.  Secondary Research

18.5.  Assumptions

18.6.  Limitations

18.7.  Report FAQs

19.  Research Findings & Conclusion

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of genomics market in 2025?

Genomics market was valued at USD 34.2 Billion in 2025.

What is the growth rate for the genomics market?

Genomics market size will increase at approximate CAGR of 14.6% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the market are Abbott, Agilent Technologies, Inc., BD, BGI Group, Bio-Rad Laboratories, Inc., Charles River Laboratories, Danaher Corporation, Eppendorf SE, Eurofins Scientific, F. Hoffmann-La Roche Ltd. and others.

Which region dominates the genomics market?

Europe dominates the market with an active share of 44.1%.

CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3499

Only Three Thousand Four Hundred Ninety Nine US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4499

Only Four Thousand Four Hundred Ninety Nine US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5499

Only Five Thousand Four Hundred Ninety Nine US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI